2023. Comparison of Drug Regimens (Sofosbuvir and velpatasvir versus Sofosbuvir and Daclatasvir) in Treatment of Chronic Hepatitis C Virus Patients in Terms of Efficacy and Safety . Medical Forum Monthly. 34, 10 (Oct. 2023).